Michigan Economic Development Corporation (MEDC) is also known as the slush fund for the Governor's cronies. MEDC sends out regular emails listing its various spending projects featured in the media.

Under the Snyder administration, daily emails featured 2-3 articles impacting healthcare.

Under the Whitmer administration, I see fewer than 1 per month. (Not watching as closely, I may miss a few.)

Yes, elections do make a difference.

https://www.dbusiness.com/daily-news/alerje-in-detroit-partners-with-mitsubishi-to-revolutionize-allergy-care/

Alerje in Detroit Partners with Mitsubishi to Revolutionize Allergy Care

Alerje Inc. in Detroit, which specializes in emergency medicine and food allergy management, and Mitsubishi Gas Chemical Co., a global leader in chemical and life sciences technologies, today announced a strategic partnership aimed at transforming allergy diagnosis and treatment on a global scale.

By R.J. King     |     September 19, 2024

Alerje Inc. in Detroit, which specializes in emergency medicine and food allergy management, and Mitsubishi Gas Chemical Co., a global leader in chemical and life sciences technologies, today announced a strategic partnership aimed at transforming allergy diagnosis and treatment on a global scale.

The synergy is expected to create a comprehensive, personalized allergy care solution that could significantly improve patient outcomes and quality of life. Food allergies affect 220 million people globally.

Key aspects of the partnership include:

• Joint efforts to bring advanced allergy diagnostic platforms to the United States market.
• Integration of food allergy technologies, aiming to create a holistic approach to personalized allergy care.
• This collaboration aligns with MGC’s strategic long-term plan, focusing on medical and food sectors.

“This partnership with MGC represents a significant milestone in our mission to improve the lives of millions affected by allergies,” says Javier Evelyn, founder and CEO of Alerje. “With our powers combined, we’re poised to deliver unprecedented advancements in allergy diagnosis and management.”

The partnership focuses on rethinking food allergy care. The work combines better testing with innovative therapies, aiming to change how people live with food allergies. The goal is to help people with food allergies live freely, not just cope with symptoms.

“We are excited about the potential of this collaboration with Alerje,” says Yoshinori Isahaya, director, managing executive officer at MGC. “Together, we aim to set new standards in allergy care, leveraging our combined technologies and expertise to address unmet needs in both the U.S. and Japanese markets.”

Alerje integrates emergency medicine with AI enabled digital health tools, and offers a remote patient monitoring platform backed by the National Science Foundation.

The platform gathers and processes vital information as well as predicts treatment outcomes, which enhances care strategies for allergists. Alerje’s internationally patented technology combines a low-cost life-saving epinephrine auto-injector with a smartphone case, ensuring patients have immediate access to medication, thus redefining adherence and emergency response.

Mitsubishi Gas Chemical is a leading global chemical company that develops and manufactures a wide range of products in the fields of basic chemicals, fine chemicals, and functional materials. With a strong focus on innovation and sustainability, MGC contributes to society through chemistry-based solutions.

For more information, visit alerje.com/.